Study Identifies Predictors of Anti-TNF Nonresponse in Pediatric IBD

Anti-TNF therapies show strong 3-year durability in pediatric IBD, with new clinical markers helping predict early nonresponse in Crohn’s disease and UC/IBD-unclassified cases.

Read the full article here

Related Articles